Pharmaceutical Companies Compete to Develop New Cholesterol Drugs
Major pharmaceutical companies like Novartis, Amgen, and Eli Lilly are racing to develop new medications aimed at reducing harmful Lp(a) cholesterol levels, which significantly impact heart health. It is estimated that one in five people worldwide suffers from elevated levels of this type of cholesterol.